Abstract
The long-term durability of viral-load suppression provided by the three original antiretroviral drugs is not well characterised. We estimated the proportion of patients who had extensive triple-class failure during long-term follow-up and examined characteristics associated with an increased rate of failure.
Original language | English |
---|---|
Pages (from-to) | 1923-8 |
Number of pages | 6 |
Journal | The Lancet |
Volume | 370 |
Issue number | 9603 |
DOIs | |
Publication status | Published - 8 Dec 2007 |
Keywords / Materials (for Non-textual outputs)
- Adult
- Anti-Retroviral Agents
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- Cohort Studies
- Female
- Follow-Up Studies
- Great Britain
- HIV Infections
- Humans
- Male
- Reverse Transcriptase Inhibitors
- Treatment Failure
- Viral Load